ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other.
Publication
, Journal Article
Khazanie, P; Newby, LK
Published in: Ann Intern Med
May 21, 2013
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
May 21, 2013
Volume
158
Issue
10
Start / End Page
JC2 / JC3
Location
United States
Related Subject Headings
- Propanolamines
- Myocardial Infarction
- Humans
- Heart Failure
- General & Internal Medicine
- Carbazoles
- Adrenergic beta-Antagonists
- Adrenergic beta-1 Receptor Antagonists
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Khazanie, P., & Newby, L. K. (2013). ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other. Ann Intern Med, 158(10), JC2–JC3. https://doi.org/10.7326/0003-4819-158-10-201305210-02002
Khazanie, Prateeti, and L Kristin Newby. “ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other.” Ann Intern Med 158, no. 10 (May 21, 2013): JC2–3. https://doi.org/10.7326/0003-4819-158-10-201305210-02002.
Khazanie P, Newby LK. ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other. Ann Intern Med. 2013 May 21;158(10):JC2–3.
Khazanie, Prateeti, and L. Kristin Newby. “ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other.” Ann Intern Med, vol. 158, no. 10, May 2013, pp. JC2–3. Pubmed, doi:10.7326/0003-4819-158-10-201305210-02002.
Khazanie P, Newby LK. ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other. Ann Intern Med. 2013 May 21;158(10):JC2–JC3.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
May 21, 2013
Volume
158
Issue
10
Start / End Page
JC2 / JC3
Location
United States
Related Subject Headings
- Propanolamines
- Myocardial Infarction
- Humans
- Heart Failure
- General & Internal Medicine
- Carbazoles
- Adrenergic beta-Antagonists
- Adrenergic beta-1 Receptor Antagonists
- 3202 Clinical sciences
- 11 Medical and Health Sciences